Patent Assignment
Reel/Frame 022960/0109
Assignment of Assignor's Interest
Recorded: 2009-07-15
Pages: 3
Assignor
SANOFI-AVENTIS DEUTSCHLAND GMBH
Executed: 2008-09-26
Assignee
SOLACE PHARMACEUTICALS INC.
FOUR CAMBRIDGE CENTER, 2ND FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Xanthine Derivatives for the Treatment of Secondary Nerve Cell Damage and Functional Disorders After Cranio-Cerebral Traumas
Patent:
5,409,935 →
Application:
07/909,389 →
The Use of 1-(5-Oxohexyl)-3-Methyl-7-N-Propylxanthine in Vascular Surgery
Patent:
5,475,002 →
Application:
08/155,535 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Aug 3, 1992
From: SCHUBERT, HANS-PETER; GROME, JOHN J.; KITTNER, BARBARA; RUDOLPHI, KARL
To: HOECHST AKTIENGESELLSCHAFT
Reel/Frame 006169/0092 →
Change of Name
Aug 18, 2000
From: HOECHST MARION ROUSSEL DEUTSCHLAND GMBH
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 011019/0234 →
Assignment of Assignor's Interest
Mar 26, 2002
From: HOECHST AKTIENGESELLSCHAFT (HOECHST AG)
To: AVENITS PHARMA DETUSCHLAND GMBH (AVENTIS PHARMA)
Reel/Frame 012721/0315 →
Assignment of Assignor's Interest
Mar 26, 2002
From: HOECHST AKTIENGESELLSCHAFT (HOECHST AG)
To: AVENTIS PHARMA DEUTSCHLAND GMBH (AVENTIS PHARMA)
Reel/Frame 012721/0485 →
Change of Name
Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
Security Agreement
Nov 6, 2009
From: SOLACE PHARMACEUTICALS INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 023471/0973 →
Release of Security Interest
Nov 3, 2011
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: SOLACE PHARMACEUTICALS INC.
Reel/Frame 027169/0426 →